Q3 2024 Alignment Healthcare Inc Earnings Call Transcript
Key Points
- Alignment Healthcare Inc (ALHC) reported a 58% year-over-year growth in health plan membership, surpassing their year-end guidance.
- Total revenue for the third quarter was $692 million, marking a 52% increase year-over-year and 62% growth excluding ACO reach.
- The company achieved an adjusted EBITDA of positive $6 million, reaching the high end of their guidance range for the second consecutive quarter.
- 98% of health plan members are in plans rated four stars or above for 2025, with significant star rating achievements in California, Nevada, and North Carolina.
- ALHC is well-positioned for future growth with a focus on profitability and margin expansion, expecting at least 20% growth in 2025.
- The company faces challenges adapting to CMS's higher star standards and tighter reimbursement, which affects many organizations in the industry.
- Despite strong growth, the mix of new members has modestly increased the Medical Benefit Ratio (MBR), impacting profitability.
- The company has had to adjust its guidance ranges due to the timing of certain clinical initiatives and investments, affecting gross profit and SG&A expenses.
- There is ongoing pressure from new membership on MBR, as new members typically have higher MBRs.
- ALHC's star ratings, while strong, still face challenges with CAPS scores, which remain a point of concern.
Good afternoon and welcome to Alignment Healthcare third quarter 2024 earnings conference call and webcast. (Operator Instructions) Please note that this event is being recorded. Leading today's call are John Kao, founder and CEO and Thomas Freeman, Chief Financial Officer.
Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions and information currently available to us descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the EC including the risk factors section for our annual report on form 10-K for the fiscal year ended December 31st 2023.
Although we believe our expectations are reasonable, we undertake no obligation to revise any statements to reflect changes that occur after this call.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
